Do 21-Gene Recurrence Score Influence Chemotherapy Decisions in T1bN0 Breast Cancer Patients?

Purpose: Hormone receptor (HR)-positive breast cancer patients with tumor size ≤1.0 cm and negative node have favorable outcomes. The 21-gene Recurrence Score (RS) could predict response to chemotherapy for HR+ breast cancer, but its role in T1bN0 disease is challenging. Methods: T1bN0 breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jing, Wu, Jiayi, Huang, Ou, He, Jianrong, Li, Zhu, Chen, Weiguo, Li, Yafen, Chen, Xiaosong, Shen, Kunwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236800/
https://www.ncbi.nlm.nih.gov/pubmed/32477946
http://dx.doi.org/10.3389/fonc.2020.00708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236800/
https://www.ncbi.nlm.nih.gov/pubmed/32477946
http://dx.doi.org/10.3389/fonc.2020.00708

Ejemplares similares